一种用于晚期乳腺癌的新型抗雌激素药物。ICI46474的早期临床评估。
A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474.
作者信息
Cole M P, Jones C T, Todd I D
出版信息
Br J Cancer. 1971 Jun;25(2):270-5. doi: 10.1038/bjc.1971.33.
Abstract
An introductory clinical trial of the anti-oestrogenic agent IC146474 in late or recurrent carcinoma of the breast is described.Forty-six patients have been treated, of whom 10 have shown a good response. This is of the same order as that seen with oestrogens and androgens.The particular advantage of this drug is the low incidence of troublesome side effects.
摘要
本文描述了抗雌激素药物IC146474用于晚期或复发性乳腺癌的初步临床试验。46例患者接受了治疗，其中10例有良好反应。这与使用雌激素和雄激素时的情况相当。这种药物的特别优势在于不良副作用的发生率较低。
相似文献
1
A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474.一种用于晚期乳腺癌的新型抗雌激素药物。ICI46474的早期临床评估。
Br J Cancer. 1971 Jun;25(2):270-5. doi: 10.1038/bjc.1971.33.
2
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.乳腺癌的抗雌激素治疗：两种剂量水平他莫昔芬的试验
Br Med J. 1973 Jan 6;1(5844):13-4. doi: 10.1136/bmj.1.5844.13.
3
New synthetic agent for the induction of ovulation: preliminary trials in women.新型促排卵合成剂：女性初步试验
Br Med J. 1971 Jan 16;1(5741):152-4. doi: 10.1136/bmj.1.5741.152.
4
Hormone therapy in metastatic breast cancer: clinical response and urinary gonadotrophins.转移性乳腺癌的激素治疗：临床反应与尿促性腺激素
Acta Endocrinol (Copenh). 1965 Nov;50(3):345-56. doi: 10.1530/acta.0.0500345.
5
6
[Endocrine and cytostatic therapy of metastasizing breast cancer in the female].
Dtsch Med Wochenschr. 1977 Oct 14;102(41):1477-80. doi: 10.1055/s-0028-1105515.
7
Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
Cancer Chemother Rep. 1974 Nov-Dec;58(6):861-5.
8
Androgens and anabolic steroids.雄激素和合成代谢类固醇。
Br Med J. 1969 Apr 19;2(5650):165-7.
9
[Vocal disturbances after treatment with androgenic and anabolic hormones (author's transl)].[雄激素和合成代谢激素治疗后的嗓音障碍（作者译）]
MMW Munch Med Wochenschr. 1974 Oct 4;116(40):1715-20.
引用本文的文献
1
Behavior of Osteoblastic Lineage Cells When in the Presence of Tamoxifen: In Vitro and In Vivo Studies on Osseointegration.成骨细胞系细胞在他莫昔芬存在时的行为：骨整合的体外和体内研究
Dent J (Basel). 2025 Aug 1;13(8):351. doi: 10.3390/dj13080351.
2
Tamoxifen induces PI3K activation in uterine cancer.他莫昔芬可诱导子宫癌中的PI3K激活。
Nat Genet. 2025 Aug 22. doi: 10.1038/s41588-025-02308-w.
3
Advancing equitable access to innovation in breast cancer.推进乳腺癌创新的公平可及性。
NPJ Breast Cancer. 2025 Jul 10;11(1):71. doi: 10.1038/s41523-025-00768-1.
4
Targeting Oestrogen Receptor Signalling in Breast Cancer Therapy.靶向雌激素受体信号传导在乳腺癌治疗中的应用
Adv Exp Med Biol. 2025;1464:449-474. doi: 10.1007/978-3-031-70875-6_22.
5
Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer.雌激素受体突变型乳腺癌的当前治疗机遇
Biomedicines. 2024 Nov 26;12(12):2700. doi: 10.3390/biomedicines12122700.
6
Today's cancer research and treatment - highly sophisticated and molecularly targeted, yet firmly bolstered in the classical theories.当今的癌症研究和治疗——高度复杂且具有分子靶向性，但仍牢牢扎根于经典理论之中。
J Appl Biomed. 2024 Sep;22(3):123-128. doi: 10.32725/jab.2024.016. Epub 2024 Sep 2.
7
Proteomic Analysis Reveals Major Proteins and Pathways That Mediate the Effect of 17-β-Estradiol in Cell Division and Apoptosis in Breast Cancer MCF7 Cells.蛋白质组学分析揭示了介导 17-β-雌二醇在乳腺癌 MCF7 细胞细胞分裂和细胞凋亡中作用的主要蛋白质和途径。
J Proteome Res. 2024 Nov 1;23(11):4835-4848. doi: 10.1021/acs.jproteome.4c00102. Epub 2024 Oct 11.
8
miR-770-5p-induced cellular switch to sensitize trastuzumab resistant breast cancer cells targeting HER2/EGFR/IGF1R bidirectional crosstalk.miR-770-5p诱导细胞转变，使靶向HER2/EGFR/IGF1R双向串扰的曲妥珠单抗耐药乳腺癌细胞致敏。
Turk J Biol. 2024 Feb 5;48(2):153-162. doi: 10.55730/1300-0152.2690. eCollection 2024.
9
Cancer treatments: Past, present, and future.癌症治疗：过去、现在和未来。
Cancer Genet. 2024 Aug;286-287:18-24. doi: 10.1016/j.cancergen.2024.06.002. Epub 2024 Jun 17.
10
Comparative metabolomics of MCF-7 and MCF-7/TAMR identifies potential metabolic pathways in tamoxifen resistant breast cancer cells.MCF-7和MCF-7/TAMR的比较代谢组学确定了他莫昔芬耐药乳腺癌细胞中的潜在代谢途径。
Am J Transl Res. 2024 Apr 15;16(4):1337-1352. doi: 10.62347/MJLN5908. eCollection 2024.
本文引用的文献
1
New synthetic agent for the induction of ovulation: preliminary trials in women.新型促排卵合成剂：女性初步试验
Br Med J. 1971 Jan 16;1(5741):152-4. doi: 10.1136/bmj.1.5741.152.
2
Role of estrogens in ovulation: A study using the estrogen-antagonist, I.C.I. 46,474.
Endocrinology. 1970 Sep;87(3):542-51. doi: 10.1210/endo-87-3-542.
Zotero 插件